Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors

• Published in: BMC infectious diseases 2014-04, Vol.14 (1), p.218-218, Article 218
• Main Authors: Flichman, Diego M, Blejer, Jorgelina L, Livellara, Beatriz I, Re, Viviana E, Bartoli, Sonia, Bustos, Juan A, Ansola, Claudia P, Hidalgo, Susana, Cerda, Martin E, Levin, Alicia E, Huenul, Adriana, Riboldi, Victoria, Treviño, Elena M C, Salamone, Horacio J, Nuñez, Felix A, Fernández, Robert J, Reybaud, Juan F, Campos, Rodolfo H
• Format: Article
• Language: English
• Subjects: Adult; Analysis; Antibodies, Viral - blood; Architects; Argentina - epidemiology; Blood & organ donations; Blood donors; Blood Donors - statistics & numerical data; Blood transfusion; Disease prevention; Disease transmission; Epidemiology; Female; Health aspects; Health care; Hepacivirus - immunology; Hepatitis B; Hepatitis B - epidemiology; Hepatitis B Surface Antigens - blood; Hepatitis B virus; Hepatitis B virus - immunology; Hepatitis C; Hepatitis C - epidemiology; Hepatitis C Antibodies - blood; Hepatitis C virus; HIV; HIV (Viruses); HIV - immunology; HIV Infections - epidemiology; Hospitals; Human immunodeficiency virus; Humans; Immune system; Infections; Male; Middle Aged; Prevalence; Retrospective Studies; Serology; Statistics; Viruses
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/1471-2334-14-218

Transfusion-transmitted infections are a major problem associated with blood transfusion. The aim of this study was to determine prevalence and trends of HBV, HCV and HIV in blood donors in Argentina. A retrospective study was carried out in blood donors of 27 transfusion centers covering the whole country over a period of eight years (2004-2011). Serologic screening assays for HBsAg, anti-HBc, anti-HCV, and anti-HIV were performed in all centers and nucleic acid amplification testing (NAT) was performed in 2 out of the 27 centers. The 2,595,852 samples tested nationwide from 2004 to 2011 showed that the prevalence of HBsAg decreased from 0.336% to 0.198% (p < 0.0001), that of anti-HBc from 2.391% to 2.007% (p < 0.0001), that of anti-HCV from 0.721% to 0.460%, (p < 0.0001) and that of anti-HIV from 0.208% to 0.200 (p = 0.075). The prevalence of HBV, HCV and HIV was unevenly distributed among the different regions of the country. Two out of 74,838 screening- negative samples were positive in NAT assays (1 HIV-RNA and 1 HCV-RNA); moreover, HBV-DNA, HCV-RNA and HIV-RNA were detected in 60.29, 24.54 and 66.67% of screening-positive samples of the corresponding assays. As regards donors age, positive HBV-DNA and HCV-RNA donors were significantly older than healthy donors (46.6, 50.5 and 39.5 y respectively, p < 0.001). Argentina has a low prevalence of HBsAg, anti-HCV and anti-HIV in blood donors, with a decreasing trend for HBsAg, anti-HBc and anti-HCV but not for anti-HIV over the last 8 years. The uneven distribution of transfusion-transmitted infections prevalence among the different regions of the country highlights the need to implement regional awareness campaigns and prevention. The discrepancy between samples testing positive for screening assays and negative for NAT assays highlights the problem of blood donors who test repeatedly reactive in screening assays but are not confirmed as positive upon further testing. The uneven distribution of age between healthy donors and NAT-positive donors could be related to changes in risks of these pathogens in the general population and might be attributed to a longer exposure to transmission risk factors in elderly people.